TrialThe New England journal of medicine2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
A Michael Lincoff et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
362 papers cite itlatest 60 shown
this paperpooled ittrialcites it